Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
64,917,500
-
Shares change
-
-3,005,029
-
Total reported value, excl. options
-
$3,634,217,578
-
Value change
-
-$158,677,402
-
Put/Call ratio
-
6%
-
Number of buys
-
102
-
Number of sells
-
77
-
Price
-
$55.98
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q4 2024
As of 31 Dec 2024 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,917,500 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., PRIMECAP MANAGEMENT CO/CA/, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, NEA Management Company, LLC, Frazier Life Sciences Management, L.P., STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This table shows 239 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.